HUTOX

Product Overview

HUTOX is a South Korean botulinum toxin type A injectable medicine manufactured by Huons BioPharma Co., Ltd. Available in 50U, 100U and 200U vial strengths, HUTOX contains Clostridium botulinum toxin type A with albumin and sodium chloride as excipients. The product is supplied as a sterile, lyophilized powder and requires preparation according to its approved prescribing information. HUTOX is the international export brand associated with LIZTOX, the corresponding product marketed in South Korea. Its approved indications and regulatory status vary by destination market.

Key Features

• Three Available Strengths: HUTOX is documented in 50-unit, 100-unit and 200-unit formulations, allowing professional buyers to compare different vial strengths within the same product family.
• Botulinum Toxin Type A: The active ingredient temporarily inhibits acetylcholine release at cholinergic nerve terminals, producing a localized reduction in neuromuscular activity when used according to approved labeling.
• Lyophilized Powder Formulation: HUTOX contains freeze-dried botulinum toxin type A in a clear glass vial. It is not supplied as a ready-to-inject liquid formulation.
• Albumin-Based Stabilizing System: The registered formulation contains albumin and sodium chloride as excipients. These ingredients support the pharmaceutical formulation and are identified in the Korean regulatory records.
• Established Korean Pharmaceutical Lineage: HUTOX is the export name associated with LIZTOX, Huons BioPharma's domestic botulinum toxin product. The manufacturer documents the relationship between the two brands in its international product information.

Composition & Specifications

HUTOX is the export designation associated with the Korean LIZTOX product family. The specifications above are based on manufacturer information and the corresponding Korean pharmaceutical registrations. Export packaging, approved indications and labeling may differ by market. Confirm the original product carton and current prescribing information for the selected HUTOX presentation.

How HUTOX Works

Botulinum toxin type A is a neurotoxic protein produced by Clostridium botulinum. Its pharmacological action involves the inhibition of acetylcholine release at cholinergic nerve terminals. Acetylcholine is a neurotransmitter responsible for transmitting signals between motor nerves and skeletal muscles.

After entering the presynaptic nerve terminal, the active toxin light chain cleaves SNAP-25, a protein involved in the SNARE complex required for synaptic vesicle fusion. This interferes with acetylcholine release and temporarily reduces neuromuscular transmission in the affected muscles.

In authorized aesthetic applications, this mechanism can temporarily improve the appearance of dynamic facial wrinkles associated with repeated muscle contraction. The corresponding Korean LIZTOX registration includes indications for moderate to severe glabellar lines and lateral canthal lines in adults aged 19–65.

Botulinum toxin potency is measured using product-specific biological assays. HUTOX units are not interchangeable with the units of other botulinum toxin products, even when their vial labels display the same numerical strength.

Available Variants

HUTOX is documented in three vial strengths: 50U, 100U and 200U. These formulations contain the same active ingredient and listed excipients but differ in their labeled biological potency per vial.

All three strengths are documented by Huons BioPharma and are associated with separate Korean pharmaceutical registrations under the LIZTOX name. The single-vial presentation reflects the referenced registered packaging. Export-market configurations should be checked against the actual supplied SKU. Vial strength does not represent a recommended clinical treatment dose.

Professional Product Selection Considerations

Professional buyers comparing HUTOX products should verify the exact vial strength, manufacturing identity, packaging and destination-market authorization. The international HUTOX brand and Korean LIZTOX brand share a documented product relationship, but their market-specific labeling must be reviewed independently.

• Confirm the Vial Strength: Identify HUTOX 50U, 100U or 200U from the original manufacturer label. Do not confuse labeled vial potency with treatment dosage or reconstitution concentration.
• Verify the Manufacturer: HUTOX is manufactured by Huons BioPharma, a specialized biopharmaceutical company within the Huons Group. Review the original carton and manufacturer documentation before procurement.
• Distinguish HUTOX from LIZTOX: HUTOX is the export brand, while LIZTOX is the corresponding Korean domestic product name. Confirm the product registration and approved labeling applicable to the intended destination market.
• Review Composition: The registered formulation contains botulinum toxin type A, albumin and sodium chloride. Buyers should review the official ingredient information and applicable prescribing precautions.
• Verify Cold-Chain Requirements: The referenced Korean product registrations specify refrigeration at 2–8°C. Confirm the supplied product's batch number, expiration date, original packaging and storage history.

Storage & Handling

The corresponding Korean pharmaceutical registrations specify storage in a sealed container under refrigeration at 2–8°C (36–46°F). The registered shelf life is 36 months from the date of manufacture for the documented 50U, 100U and 200U products. Follow the original label and current market-specific prescribing information.

HUTOX is supplied as a lyophilized powder in a sterile vial. It is not a ready-to-inject liquid product. Preparation, administration and post-preparation handling must follow the approved product-specific instructions. Do not use expired products or vials with compromised packaging.

Botulinum toxin products can cause adverse reactions, including injection-site discomfort, localized muscle weakness and hypersensitivity. Serious complications may occur if toxin effects spread beyond the intended area, potentially causing difficulty swallowing, speaking or breathing.

HUTOX is a prescription injectable medicine intended for appropriately qualified healthcare professionals. Product-specific contraindications, warnings, approved indications and applicable regulatory requirements must be reviewed before clinical use. Botulinum toxin potency units must not be converted between brands.

Frequently Asked Questions